"Das Helios Park-Klinikum mit seiner über einhundertjährigen Geschichte ist fester Teil der Leipziger Gesundheitsversorgung. Mit unseren Somatischen und Psychiatrischen Kliniken sowie der Suchtbehandlung bieten wir unseren Patienten moderne Medizin für Körper und Seele."

During the past decade, Park-Krankenhaus Leipzig conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Park-Krankenhaus Leipzig" #1 sponsor was "Provascular GmbH" with 3 trials, followed by "Biotronik AG" with 2 trials sponsored, "Medtronic Endovascular" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Altura Medical Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Park-Krankenhaus Leipzig" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "CERES GmbH" with 1 trials as a collaborator, "Dr. Köhler Chemie (Alsbach-Hähnlein, Germany)" with 1 trials as a collaborator, "GEA (Frederiksberg, Denmark)" with 1 trials as a collaborator and "HP-Medica (Augsburg, Germany)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Park-Krankenhaus Leipzig" are "Atherosclerosis" (4 trials), "Peripheral Artery Disease" (4 trials), "Arteriosclerosis" (3 trials), "Claudication" (3 trials) and "Peripheral Vascular Disease" (3 trials). Many other conditions were trialed in "Park-Krankenhaus Leipzig" in a lesser frequency.

Most popular intervention types in "Park-Krankenhaus Leipzig" are "Device" (13 trials), "Procedure" (3 trials), "Drug" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Passeo-18 Lux DRB" (2 trials), "Standard PTA (POBA)" (2 trials), "4F portfolio products from Biotronik" (1 trials), "Altura Endograft System" (1 trials) and "Chemotherapy arm B" (1 trials). Other intervention names were less common.

The vast majority of trials in "Park-Krankenhaus Leipzig" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Park-Krankenhaus Leipzig". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Park-Krankenhaus Leipzig, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Park-Krankenhaus Leipzig, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Park-Krankenhaus Leipzig has several departments that took part in Clinical trials: "Universität Leipzig - Herzzentrum" - 14 trials, "Heart Center Leipzig at University of Leipzig Department of Internal Medicine/Cardiology" - 7 trials, "University of Leipzig - Heart Center" - 36 trials, "Herzzentrum Leipzig, Klinik für Kinderkardiologie" - 2 trials